MEDICLIN's 2025 Financial Results Set Stage for Growth

In 2025, MEDICLIN AG reported a 4.8% rise in revenue to EUR 784.5 million, alongside a 3.5% increase in EBIT, improving to EUR 55.4 million. The company treated 108,524 inpatients, marking a slight increase from the previous year.

The Post-Acute segment saw a significant 9.6% revenue increase to EUR 532.0 million, with an 18% operating profit rise. In contrast, the Acute Care segment experienced a 5% revenue drop due to asset sales, resulting in a EUR 4.9 million operating loss. The Care segment faced a minor revenue rise but ended with a negative result due to increased staff costs.

In 2026, MEDICLIN aims to continue its strategy, focusing on rehabilitation and sustainable care, projecting revenue growth between 3.5% and 6.5%, with expected EBIT between EUR 57.0 million and EUR 72.0 million.